Purpose-built for physicians GLP-1s may reduce all-cause mortality, adverse events in sickle cell disease Key takeaways: GLP-1 receptor agonist use appeared linked to lower risk for all-cause mortality among people with sickle cell disease
Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy
Moyad and Miner on weight loss and mens health, check out their discussion on Testosterone, Weight Loss / Weight Gain, and Testosterone Replacement Therapy (TRT)
REM sleep also modulates metabolism and neurogenesis in ways that promote hippocampal learning
Researchers should consult the full Phase 2 safety data and any updated Phase 3 findings when designing research protocols involving this compound
daily insulin in trials) = 2 To view or add a comment, sign in Semaglutide generics trigger off-label possibilities among missing weight-loss tag While generic formulations are approved for both diabetes and weight management, some are cleared only for treating type-2 diabetes, creating a divergence in market potential, despite having approval for higher dosage strengths used in chronic weight management
